Lung cancer screening in Finland: a prospective randomized trial
This study suggests that LDCT screening for lung cancer is feasible in Finland. The screening examination uptake was high with both screening rounds, while the positive predictive value for lung cancer detection remained at good level.
Authors
- Antti Jekunen (ORCID: https://orcid.org/0000-0002-6183-0169)
- Tuula Vasankari (ORCID: https://orcid.org/0000-0002-1413-8970)
- Sanna Iivanainen (ORCID: https://orcid.org/0000-0003-1075-1134)
- Heidi Andersén (ORCID: https://orcid.org/0000-0001-5923-5865)
- Jussi Pekka Koivunen (ORCID: https://orcid.org/0000-0001-6425-1640)
- Airi Jartti
- Riitta Kaarteenaho (ORCID: https://orcid.org/0000-0002-1903-2235)
- Viktor Wichmann (ORCID: https://orcid.org/0000-0001-9235-8947)
- Lauri Mattila
- Veli‐Pekka Kokkonen
- Antti Kurtti
Institutions
- University of Turku (FI)
- Oulu University Hospital (FI)
- Vaasa Central Hospital (FI)
- Finnish Lung Health Association (FI)
- Oulu University of Applied Sciences (FI)
- University of Oulu (FI)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-06-11
- DOI
- https://doi.org/10.2340/1651-226x.2025.43093
- Citations
- 4
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.07
Funders
- AstraZeneca
- Syöpäsäätiö